Dec 10, 2014 sun pharmaceutical industries ltd has moved closer to finalizing its acquisition of ranbaxy laboratories. Merger between sun pharma and daiichi sankyos ranbaxy. It is an indian multinational pharmaceutical company headquatered in mumbai. Competition commission of india combination registration. Sunpharma and ranbaxy merge in 2014 to create indias largest and the worlds. On april 06, 2014, indiabased pharmaceutical companies, sun pharmaceutical industries sun pharma and ranbaxy laboratories limited ranbaxy, entered into an agreement under which sun pharma would acquire 100% of ranbaxy in an all stocktransaction. Over the past 5 days, ranbaxy shares jumped 22%, while sun pharma. Press release for closure of sun ranbaxy merger sun pharma.
Sun pharmaceutical on wednesday told the bse that six per cent of its medical representatives who were working for the erstwhile ranbaxy are refusing to file the daily activity reports dar on its. C201405170 page 3 of 56 fair competition for greater good proposed combination 7. Merger acquisition sun pharma ranbaxy free download as powerpoint presentation. Sun pharma, a large indian drug maker, has announced acquisition of ranbaxy laboratories, another indian pharmaceutical company. The combination of sun pharma and ranbaxy creates the.
Whether the merger is positive for sun original shareholders in the long run. Each company brings its own strengths to the merger. Ranbaxy was present in number of countries in the world with offices in most of them. Sun pharma ranbaxy ppt 1 free download as powerpoint presentation.
Sun pharma ranbaxy nishith desai associates nda is a research based international law firm with offices in mumbai, bangalore, silicon valley, singapore, new delhi, munich. Pharmacy sector the pharmaceutical industry develops, produces, and markets drugs or pharmaceuticals licensed for use as medications. Read expert opinions, top news, insights and trends on. What was sun pharmas rationale for acquiring ranbaxy.
Investors welcomed the completion of the merger, with sun pharma shares rising 1. But the merger came with its fair share of challenges for sun pharma. The big news of the week was about a mega merger of two of indias largest pharma companies, sun pharma and ranbaxy. Apr 08, 2014 sunpharma and ranbaxy merge in 2014 to create indias largest and the worlds fifth largest pharma company. It is the third largest in terms of volume and thirteenth largest in terms of value. Sunpharma ranbaxy acquisition free download as powerpoint presentation. Ranbaxy will merge into sun pharma and the shareholders of ranbaxy will. It was a well thought out decision by the management of sun pharmaceutical industries. Knowledge sun pharmaceuticals acquisition of ranbaxy. Why is sun pharmaceutical in trouble after the ranbaxy. Read more about mckinsey hired to assist merger of sun, ranbaxy on business standard. Us fda approval, including many highvalue ftf first to file opportunities. The company have received approval from the competition commission of india, subject to certain product divestments and other terms.
Daiichi sankyo is also a majority shareholder of ranbaxy. The merger will create the worlds fifth largest specialtygeneric pharmaceutical company and the largest player in the indian pharma market. Mar 25, 2015 through this merger completion, ranbaxy will be delisted from the indian stock exchanges, with ranbaxy shareholders receiving 0. The dynamics of major indian takeovers their causes. Sun pharma announces closure of merger deal with ranbaxy. In the petition, fmrai alleged that sun pharma had violated the directions given by the court at the time of the merger approval by transferring senior medical sales representatives of ranbaxy. Sun pharma to delist ranbaxy after merger huffpost india.
The sun pharma merger with ranbaxy will blend the complementary market. Sun pharmaceuticals acquisition of ranbaxy business. Sun pharma, ranbaxy rise after regulatory nods for merger. We specialize in strategic legal, regulatory and tax advice coupled with industry expertise in. Merger with ranbaxy laboratories poses challenges for sun. Taking forward its acquisition of ranbaxy laboratories, sun pharma has put in place a team of top executives, including dilip shanghvis son aalok shanghvi, to. Strategy consulting sun pharmaceuticals acquisition of ranbaxy submitted by gopinath dhavala2016pgp2 prithviraj nag2016pgp285 tushar gupta2016pgp411 environment.
The deal is a cashless share swap one where ranbaxy shareholders get 80 shares of sun pharma for every 100 shares they own. After the acquisition, sun s promoters stake will come down to 54. Sun pharma would acquire 100 percent of ranbaxy transaction. The deal has reaped the benefit in the market price also as sun pharma market price after the date of announcement of merger with ranbaxy till the record the date of merger has touch a new high to inr 1200 per share i. Sun pharma completed the acquisition of ranbaxy laboratories limited, an integrated, research based, international pharmaceutical company, on 25 th march 2015. Sun pharma readies new leadership team they have been selected based on their contribution and performance since last couple of years after several rounds of discussions supplemented with feedback from a talent mapping process. Shares of sun pharmaceutical industries and ranbaxy laboratories were trading higher by 3% each on the bourses ahead of record date set for the merger. Sun pharma, ranbaxy shares rise as court lifts stay on merger. The transaction will combine sun pharmas proven complex product. The integration, planned by sun pharma over many months, will focus on supporting strong growth. Today sun pharma is the second largest and the most profitable pharmaceutical company in india, as well as the largest pharmaceutical company by market capitalisation on the indian.
Jun 04, 2014 as announced in releases dated april 7 and 11, 2014, daiichi sankyo company, limited daiichi sankyo has entered into agreements with sun pharmaceutical industries ltd. Why is sun pharmaceutical in trouble after the ranbaxy merging. Sun pharma announces closure of merger deal with ranbaxy beginning today, integration to focus on enhancing productivity. At 1107 hours, sun pharma and ranbaxy laboratories were up 3% each at rs 1,052 and rs 837 respectively. The merger wont have too many cultural and integration issues since both companies are indian. Daiichi sankyo, the largest shareholder of ranbaxy, will become the second largest shareholder of the merged entity with a 9% stake and the right to nominate one board member. Jun 25, 2019 ranbaxy laboratories was established in 1961 and is a member of the daiichi sankyo group tokyo, japan, a leading global pharma innovator. The merger with ranbaxy laboratorie s was intended to help indias largest drug maker. Sun pharma buys ranbaxy to create worlds fifth largest specialty generic pharma company. This is a stock only merger, which means no cash will be paid out. Sun pharma was listed on the stock exchange in 1994 in an issue oversubscribed 55 times. Read more about sun pharma buys ranbaxy from japans daiichi on business standard. To study the need of sun pharma and ranbaxy merger. The indian pharmaceuticals market plays a major role in the global picture.
One of the earliest diagnoses made by sun pharma in the runup to the ranbaxy acquisition was that since the entire management was focusing on resolving the us fda. Daiichi sankyo is scheduled to acquire approximately 9% of the shares of sun pharma as a result of this merger. Sun pharma ranbaxy merger sun pharmaceutical industries ltd. Shares of sun pharma witnessed massive selling pressure, plunging over 16 percent after the drug major said it expects to take a hit on profit for the fiscal 201516 mainly due to integration process with ranbaxy. Petition against sun pharma for allegedly violating merger. Sun pharma ends merger deal with ranbaxy biopharma asia. Fda aip letter to ranbaxy laboratories updated 322009 fda news release. Read expert opinions, top news, insights and trends on the economic times. Sun pharma open to large acquisitions postranbaxy deal. Sun pharma had acquired ranbaxy for approximately rs 22,000 crore in march last year. Announcement regarding merger between sun pharma and daiichi. Sun pharmaceutical industries ltd has become the worlds fifth largest generics drugs maker after buying ranbaxy laboratories ltd from japans daiichi sankyo co. Closure of the deal about 10 days ago catapulted the sun ranbaxy combine to the top of the pharmaceutical charts with a.
Apr 08, 2014 sun pharma and ranbaxy together will be stronger. Now, under the deal with sun pharma, ranbaxy shareholders will receive 0. Sun pharma in connection with merger of ranbaxy laboratories limited ranbaxy into sun pharma. Pdf sun pharmaceutical industries ltd has become the worlds fifth largest. Mckinsey hired to assist merger of sun, ranbaxy business. The merger has fortified sun pharmas position as the worlds fifth largest specialty generic pharmaceutical. Mar 25, 2015 shares in sun pharmaceuticals industries and ranbaxy laboratories gained on wednesday after sun pharma said that all the requisite approvals have been received for the merger of ranbaxy into sun. The exchange ratio represents an implied value of rs 457 for each ranbaxy share, a premium of 18% to ranbaxy s 30day volumeweighted average share price and a premium of 24. Sun pharma buys ranbaxy to create worlds fifth largest specialty generic. Sun pharma and ranbaxy to merge, create giant pharma co. Sunpharma ranbaxy acquisition pharmaceutical industry. Sun pharma buys ranbaxy from japans daiichi business. The merger will make sun pharma the largest pharma company in india with pro. Under these agreements, ranbaxy will merge into sun pharma and the shareholders of ranbaxy will receive 0.
Reuters market eye shares in sun pharmaceutical industries ltd and ranbaxy laboratories ltd rise after a court lifted a temporary stay it imposed on the acquisition of ranbaxy by sun pharma. The merger, which is all stock, will give ranbaxy shareholders 0. The combined entity, upon successful consummation of the transaction, would be the fifthlargest specialty. Developing complex products and exploiting first to file opportunities.
The proposed combination relates to the merger of ranbaxy into sun pharma pursuant to the scheme of arrangement approved by their respective board of. Sun pharma, ranbaxy move closer to finalizing merger. Oct 23, 2015 the merger with ranbaxy by sun pharmaceuticals has given the company scale to move up the food chain in the industry but has. Talks about difference between mergers and acquisition, different types of mergers and finally the acquisition of ranbaxy by sun pharma. Ownership of ranbaxy changed twice over the course of its history. Fda takes new regulatory action against ranbaxy s paonta sahib plant in india 2252009 application integrity policy. Shares in sun pharmaceuticals industries and ranbaxy laboratories gained on wednesday after sun pharma said that all the requisite approvals have been received for the merger of ranbaxy into sun.
Last week, after announcement of closure of merger deal with ranbaxy, sun pharma said that ranbaxy will be delisted from the indian stock exchanges. Sun pharma ranbaxy deal the financial model behind. Ranbaxy the largest pharma company in india was itsel. Sunpharma and ranbaxy merge in 2014 to create indias largest and the. We specialize in strategic legal, regulatory and tax advice coupled with industry expertise in an integrated manner. Ranbaxy merger showing sharp cons as well as pros for sun pharma. Competition commission of india combination registration no. Ranbaxy pdf file each ranbaxy share, a premium of 18 to ranbaxys 30day. A merger in which sun pharma is the surviving company and ranbaxy is the company to be absorbed. Sun pharma, ranbaxy gain ahead of merger business standard news.
India is the largest provider of generic drugs globally 20 per. Information and announcements about this can be found on this page. Indian pharma market and in the us where it offers a broad portfolio of andas and firsttofile. The merger has fortified sun pharma s position as the worlds fifth largest specialty generic pharmaceutical.
Sunpharma and ranbaxy merge in 2014 to create indias largest and the worlds fifth largest pharma company. Read more about sun pharma, ranbaxy gain ahead of merger on business standard. Apr 09, 2014 the big news of the week was about a megamerger of two of indias largest pharma companies, sun pharma and ranbaxy. Mar 25, 2015 the ranbaxy deal, which closed on tuesday, was the largest acquisition in the pharmaceutical industry in sun pharma open to large acquisitions post ranbaxy home. Three of ranbaxy s plants in india, supplying products to the us, are still banned by the us food and drug administration fda. The founding family continues to hold a majority stake in the company. Experts say ranbaxy acquisition positive for sun pharma. Pharma and ranbaxy acquisition in pharmaceutical industry.
1082 1042 619 592 1249 1285 1138 787 1290 1309 1350 477 497 778 1432 898 1240 996 718 373 1452 1460 1396 1069 1125 653 1440 735 795 499 1113 925 1106 928 1409 287 876 448 611 302